A U.S. Patent and Trademark Office advisor will deliver the keynote address at an event Thursday in Indianapolis focusing on legal issues facing the biopharmaceutical industry. The Indiana University Robert H. McKinney School of Law BioPharma/Tech Law Symposium will include topics such as tech transfer, clinical trials and patents. March 6, 2015

News Release

INDIANAPOLIS, Ind. – The Center for Intellectual Property Law and Innovation at the Indiana University Robert H. McKinney School of Law will host the BioPharma/Tech Law Symposium on March 12.

Practitioners working in the field of biopharma and legal scholars with expertise in the discipline will be on hand to discuss issues such as “University Tech Transfers in BioPharma,” “Legal Issues in Clinical Trials (U.S. and Asia)” and “Patent Prosecution of Biologics,”” among other topics.

A highlight will be a keynote address from Janet Gongola, '03, senior advisor in the Office of the Under Secretary of Commerce and director of the U.S. Patent and Trademark Office.

The event, from 8 a.m. to 5:30 p.m., carries with it 7.0 hours of CLE (pending approval) with paid attendance.

To register, visit the symposium event page on the IU McKinney website, or contact Kristin Brockett at kbrocket@iupui.edu or 317-278-9160 to learn more.

Source: The Indiana University Robert H. McKinney School of Law

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}